U.S. Banks Stock News

NasdaqCM:ESTA
NasdaqCM:ESTAMedical Equipment

Is It Too Late To Consider Establishment Labs Holdings (ESTA) After A 95% One-Year Surge?

Wondering whether Establishment Labs Holdings at around US$70.04 is offering fair value or asking too much for its growth story is a natural question if you are watching the stock. The share price shows a 1.4% return over the past 7 days, 4.6% over 30 days, 1.7% year to date and 95.2% over the past year, which naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Establishment Labs Holdings in the context of the broader Medical...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Why Corvus Pharmaceuticals (CRVS) Is Down 28.0% After Rebound‑Free Soquelitinib Phase 1 Eczema Data And What's Next

In May 2026, Corvus Pharmaceuticals reported final Phase 1 data showing that its oral ITK inhibitor soquelitinib produced dose-dependent efficacy and a placebo-like safety profile in moderate-to-severe atopic dermatitis patients who had previously failed at least one topical or systemic therapy. An unusual and clinically important feature of the results was the maintenance of disease control without rebound or rescue medication during drug-free follow-up, supporting Corvus’s thesis that...
NYSE:SAM
NYSE:SAMBeverage

Is Boston Beer’s Glow-in-the-Dark LYTT Launch Quietly Rewriting the SAM Brand Strategy?

In May 2026, The Boston Beer Company launched LYTT Electric Coolers, a 15% ABV ready-to-drink line in glow-in-the-dark, recyclable, lightbulb-shaped single-serve containers across select U.S. states, while also rolling out its Twisted Tea Summer Party Pack nationwide with seasonal flavors and promotional giveaways. These product launches highlight Boston Beer’s push into high-ABV ready-to-drink beverages and experiential, packaging-led marketing designed to capture summer drinking...
NYSE:HE
NYSE:HEElectric Utilities

A Look At Hawaiian Electric Industries (HE) Valuation As Fair Value And P/E Signals Diverge

Recent performance snapshot for Hawaiian Electric Industries (HE) Hawaiian Electric Industries (HE) has drawn fresh investor attention after recent price moves, with the stock up 1.7% over the past day but down about 13% over the past month. See our latest analysis for Hawaiian Electric Industries. At a share price of $13.75, Hawaiian Electric Industries sits between an 8.9% year to date share price gain and a 29.8% total shareholder return over one year, but longer term total shareholder...
NasdaqGS:CRNT
NasdaqGS:CRNTCommunications

Ceragon Networks (CRNT) Margins Under Pressure As Q1 EPS Loss Tests Bullish Profitability Narrative

Ceragon Networks (NasdaqGS:CRNT) opened Q1 2026 with revenue of US$85.0 million and a basic EPS loss of US$0.01, setting a mixed tone for the quarter. Over recent periods, the company has seen quarterly revenue move between US$82.3 million and US$88.7 million, while EPS has swung from a profit of US$0.04 to a loss of around US$0.01. This underscores how sensitive margins remain to small shifts in performance. For investors, the latest print keeps the focus squarely on whether Ceragon can...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Assessing Bio-Techne (TECH) Valuation After Revenue Miss And Softer Emerging Biotech Demand

Bio-Techne (TECH) stock is back in focus after recent coverage of its latest results, where revenue missed expectations because of softer demand from emerging biotech customers and delayed cell therapy orders. See our latest analysis for Bio-Techne. Bio-Techne’s recent earnings news has arrived against a backdrop where the share price is down 22.91% over the past month and 21.71% year to date. However, the 1 year total shareholder return is slightly positive at 0.51%, suggesting shorter term...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Stronger Q1 Profitability And Reaffirmed Outlook Could Be A Game Changer For Amneal (AMRX)

In early May 2026, Amneal Pharmaceuticals, Inc. reported first-quarter 2026 results showing sales of US$722.52 million and net income of US$62.26 million, both higher than the same period a year earlier, while also reaffirming its full-year 2026 revenue outlook of US$3.05 billion to US$3.15 billion. The jump in quarterly net income alongside unchanged full-year guidance suggests Amneal delivered improved profitability without yet revising its longer-term expectations for 2026. We’ll now...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

Driven Brands Holdings (DRVN) Profitability Turnaround Tests Bullish Narratives On Earnings Stability

Driven Brands Holdings (DRVN) closed FY 2025 with fourth quarter revenue of US$259.6 million and basic EPS of US$0.26, capped by trailing twelve month EPS of US$0.81 on revenue of about US$1.9 billion as the company moved into profitable territory over the year despite a one off loss of US$33.5 million. Over the last few quarters, the company has seen quarterly revenue range from US$516.2 million to US$550.9 million with EPS swinging between US$0.07 and US$0.37. Trailing twelve month revenue...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

How Incyte’s (INCY) Opzelura Data and Edison AI Deal Could Reframe Its Risk Profile

In May 2026, Edison Scientific announced a collaboration with Incyte to integrate its Kosmos AI platform across Incyte’s discovery and development work, alongside new 24-week Phase 3b data for Opzelura in moderate atopic dermatitis presented at the EADV Symposium in Athens. The combination of durable Opzelura efficacy and safety data with a broad AI-driven R&D partnership highlights Incyte’s effort to improve both clinical outcomes and pipeline productivity. We’ll now examine how integrating...
NYSE:CXM
NYSE:CXMSoftware

Sprinklr (CXM) Valuation Check After A Steep Share Price Reset

Recent performance context for Sprinklr stock Sprinklr (CXM) has drawn investor attention after a period where the stock declined about 28% year to date and about 35% over the past year, despite reporting US$857.2 million in revenue and US$22.905 million in net income. See our latest analysis for Sprinklr. The recent 7-day share price return of 7.77% offers a short burst of positive momentum, although the share price is still down 28.01% year to date and the 1-year total shareholder return is...
NYSE:ACN
NYSE:ACNIT

Accenture’s AI Moves Reshape Client Operations And Undervaluation Debate

Accenture (NYSE:ACN) has invested in Aera Technology to build out agentic decision intelligence for real-time, AI-led supply chain decisions. The company has also backed XBOW, expanding its capabilities in autonomous cybersecurity. Accenture entered a large-scale AI partnership with HUMAIN in Saudi Arabia to support national-level AI adoption. These moves align with broader efforts to scale AI-driven supply chain automation and enterprise AI implementations across global clients. For...
NYSE:LOW
NYSE:LOWSpecialty Retail

Is Lowe's Companies (LOW) Attractive After Recent Share Price Weakness And Valuation Gap

If you are wondering whether Lowe's Companies at around US$221.05 a share looks like a bargain or a stock to treat with caution, the starting point is understanding what that price actually reflects. Over the short term the stock has been mixed, with a 0.3% gain over the last week, a decline of 12.7% over the last month, and a decline of 10.5% year to date, while the return over the last year is a decline of 0.9% and gains over 3 and 5 years sit at 15.1% and 25.5% respectively. That pattern...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia Ties CLEAR Partnership To Loyalty Ecosystem And Airport Experience

Expedia Group (NasdaqGS:EXPE) has announced a new partnership with CLEAR to bring expedited airport experiences directly into its travel booking platform. The collaboration connects CLEAR’s identity verification, enrollment, and travel concierge services with Expedia’s ecosystem, including the One Key loyalty program. For travelers using Expedia Group (NasdaqGS:EXPE), this partnership links trip planning with services that aim to reduce friction at the airport. CLEAR focuses on trusted...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

A Look At Credit Acceptance (CACC) Valuation After The Recent Zacks Upgrade

Credit Acceptance (CACC) is back on investors’ radar after a Zacks upgrade to Rank #2. The move is tied to higher earnings estimates and has coincided with stronger recent trading interest in the stock. See our latest analysis for Credit Acceptance. The recent Zacks upgrade comes after a strong run in the stock, with a 90 day share price return of 14.89% and a year to date share price return of 22.92%. The 1 year total shareholder return sits at 15.48%, suggesting momentum has been building...
NYSE:SAFE
NYSE:SAFESpecialized REITs

Assessing Safehold (SAFE) Valuation After New Affordable Housing Ground Leases With CRP

Safehold (SAFE) has expanded its ground lease activity into affordable housing by closing on leases for two Low Income Tax Credit communities in Santa Cruz and Santa Clarita, California, totaling 211 units targeted for delivery in 2028. See our latest analysis for Safehold. The latest affordable housing leases come after a recent shelf registration for up to 3,000,000 shares, and follow a 1 day share price return of 3.09% at US$14.66. The year to date share price performance is 7.56%, while...
NYSE:CALY
NYSE:CALYLeisure

Assessing Callaway Golf’s Valuation After Recent Share Price Momentum And Mixed Long Term Returns

Callaway Golf (CALY) has drawn investor attention after a recent stretch of mixed long term returns, with the stock up 4.0% over the past day and 32.8% year to date, while 5 year performance remains weaker. See our latest analysis for Callaway Golf. At a share price of $15.56, Callaway Golf’s recent 4.0% 1 day share price return and 32.8% year to date share price return sit alongside a very strong 1 year total shareholder return of 150.2% but weaker 3 and 5 year total shareholder returns...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

Assessing RealReal (REAL) Valuation As Earnings Beat And Higher Guidance Shift Expectations

Guidance Hike Puts Earnings Beat in Context RealReal (REAL) lifted full year 2026 revenue guidance to a range of US$770 million to US$784 million, after reporting first quarter revenue of US$189.72 million and 19% year over year growth. The company also set second quarter 2026 revenue expectations at US$186 million to US$189 million, giving investors a clearer view of near term sales trends following recent concerns about valuation and insider selling. See our latest analysis for...
NYSE:AMG
NYSE:AMGCapital Markets

A Look At Affiliated Managers Group’s Valuation After Strong Multi‑Year Shareholder Returns

Recent performance snapshot Affiliated Managers Group (AMG) has drawn attention after recent trading, with the stock last closing at US$301.34. Over the past year, total return stands at 71.17%, while year to date it is 4.32%. See our latest analysis for Affiliated Managers Group. The recent 1-day share price return of 2.18% comes after a softer spell, with the stock down 6.48% over 90 days. However, long term total shareholder returns of 71.17% over one year and 113.03% over three years...
NYSE:MET
NYSE:METInsurance

MetLife (MET) Is Up 5.7% After Strong Q1 2026 Results And Capital Returns Push - Has The Bull Case Changed?

MetLife, Inc. recently reported past first quarter 2026 results with revenue of US$19,074 million, net income of US$1,185 million and diluted EPS from continuing operations of US$1.74, alongside announcing quarterly preferred dividends across its Series A, E and F shares payable in June 2026. These updates, combined with the completion of a US$1.69 billion share repurchase program covering 21,901,426 shares since April 2025, highlight MetLife’s continued emphasis on capital returns to...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados Holdings (ARCO) Is Up 6.7% After Q1 2026 Earnings Jump, Has The Bull Case Changed?

Arcos Dorados Holdings Inc. has reported its first-quarter 2026 results, with revenue rising to US$1,215.96 million and net income to US$36.14 million, lifting basic earnings per share from continuing operations to US$0.17 from US$0.07 a year earlier. The sharp improvement in both revenue and earnings suggests that recent operational and commercial efforts are translating into stronger profitability across the business. We’ll now examine how this stronger first-quarter revenue and earnings...
NYSE:OMC
NYSE:OMCMedia

Will Leadership Reshuffle, Interpublic Integration and AI Push Change Omnicom Group's (OMC) Narrative?

Omnicom Group recently reshaped its public relations and marketing operations through leadership changes, new alliances, and the integration of Interpublic, following a strong first-quarter update on revenue and earnings. These moves, alongside Omnicom’s AI-enabled Omni platform and ongoing efficiency efforts, have prompted analysts to revisit earnings expectations and reassess the company’s longer-term positioning in data-driven marketing. We’ll now examine how the leadership reshaping...
NYSE:FAF
NYSE:FAFInsurance

A Look At First American Financial (FAF) Valuation As Analyst Upgrades And Dividend Affirmation Draw Attention

Dividend affirmation and earnings momentum put First American Financial in focus First American Financial (FAF) has drawn fresh attention after analysts raised earnings estimates, which supports a top Zacks Rank #1 rating. The company also reaffirmed its quarterly cash dividend of $0.55 per share. See our latest analysis for First American Financial. At a share price of $68.16, First American Financial has seen steady momentum recently, including an 11.59% year to date share price return and...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Did Softer Q3 Earnings and Heavy Buybacks Just Shift Fox’s (FOXA) Investment Narrative?

Earlier in May 2026, Fox Corporation reported fiscal third-quarter results showing sales of US$3,994 million and net income of US$166 million, while also disclosing that it has now repurchased 221,116,159 shares for about US$8.53 billions under its long-running buyback program. These results highlight a contrast between weaker reported earnings and management’s emphasis on resilient advertising trends, expanding distribution revenue, and growing contributions from digital platforms like Tubi...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

How Investors Are Reacting To Jazz Pharmaceuticals (JAZZ) Reaffirmed Guidance And Rare-Disease Portfolio Momentum

Jazz Pharmaceuticals recently reported a strong first quarter, citing solid commercial execution across its sleep, epilepsy, and oncology franchises, with key products Xywav, Epidiolex, Midevo, and Zepzelca driving revenue growth and management reaffirming full-year guidance while emphasizing rare disease expansion and financial readiness for potential acquisitions. For investors, the combination of double-digit growth across all promoted brands and a reiterated outlook highlights how Jazz’s...